| Heading: |
Respiratory Syncytial Virus: Vaccination |
| Question ID: |
1759177 |
| UIN: |
26780 |
| House: |
Commons |
| Date tabled: |
2025-01-27 |
| Asking Member ID: |
5247 |
| Asking Member display name: |
Sojan Joseph
|
| Asking Member handle: |
sojanuk
|
| Asking Member Twitter reference: |
@sojanuk
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of ensuring that adults aged over 60 with pre-existing conditions are included in the respiratory syncytial virus vaccination program |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-01-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Joint Committee on Vaccination and Immunisation (JCVI) keeps all vaccine programmes under review and will continue to update its advice as new evidence emerges. In October 2024, the JCVI agreed that it would need to formally review, in detail, the evi... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |